Learn more at: http://www.flumistquadrivalent.com/isi.html
Please see full Prescribing Information available at: https://www.azpicentral.com/pi.html?product=flumistquadrivalent
Official video from FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) from AstraZeneca (Intended for US residents only).
This school year help protect your kids from flu. Ask your doctor about FluMist® Quadrivalent, the only nasal spray flu vaccine.
IMPORTANT SAFETY INFORMATION
• You should not get FLUMIST QUADRIVALENT if you have a severe allergy to eggs or to any inactive ingredient in the vaccine; have ever had a life-threatening reaction to influenza vaccinations; or are 2 through 17 years old and take aspirin or medicines containing aspirin – children or adolescents should not be given aspirin for 4 weeks after getting FLUMIST QUADRIVALENT unless your healthcare provider tells you otherwise.
• Children under 2 years old have an increased risk of wheezing (difficulty with breathing) after getting FLUMIST QUADRIVALENT.
• Tell your healthcare provider if you or your child are currently wheezing; have a history of wheezing if under 5 years old; have had Guillain-Barré syndrome; have a weakened immune system or live with someone who has a severely weakened immune system; have problems with your heart, kidneys, or lungs; have diabetes; are pregnant or nursing; or are taking a medication used to treat influenza like Tamiflu®*, Relenza®*, amantadine, or rimantadine.
• The most common side effects are runny or stuffy nose, sore throat, and fever over 100°F.
APPROVED USE
FLUMIST QUADRIVALENT is a vaccine that is sprayed into the nose to help protect against influenza. It can be used in people 2 through 49 years old. FLUMIST QUADRIVALENT may not prevent influenza in everyone who gets vaccinated.
Please see full Prescribing Information, including Patient Information at https://www.flumistquadrivalent.com/
FLUMIST is a registered trademark of the AstraZeneca group of companies.
*Tamiflu and Relenza are registered trademarks of their respective owners.
0 Comments